FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385791346> ?p ?o ?g. }

• W4385791346 abstract "Abstract Background The discovery of driver oncogenes for thyroid carcinomas and the identification of genomically targeted therapies to inhibit those oncogenes have altered the treatment algorithm in thyroid cancer (TC), while germline testing for RET mutations has become indicated for patients with a family history of RET gene mutations or hereditary medullary TC (MTC). In the context of an increasing number of selective RET inhibitors approved for use, this paper aims to describe challenges and barriers affecting providers’ ability to deliver optimal care for patients with RET-altered TC across the patient healthcare journey. Methods A mixed-method educational and behavioral needs assessment was conducted in Germany (GER), Japan (JPN), the United Kingdom (UK), and the United States (US) prior to RET-selective inhibitor approval. Participants included medical oncologists (MO), endocrinologists (EN) and clinical pathologists (CP) caring for patients affected with TC. Data collection tools were implemented in three languages (English, German, Japanese). Qualitative data were coded and thematically analyzed in NVivo. Quantitative data were analyzed via frequency and crosstabulations in SPSS. The findings presented here were part of a broader study that also investigated lung cancer challenges and included pulmonologists. Results A total of 44 interviews and 378 surveys were completed. Suboptimal knowledge and skills were self-identified among providers, affecting (1) assessment of genetic risk factors (56%, 159/285 of MOs and ENs), (2) selection of appropriate genetic biomarkers (59%, 53/90 of CPs), (3) treatment plan initiation (65%, 173/275 of MOs and ENs), (4) management of side effects associated with multitargeted tyrosine kinase inhibitors (78%, 116/149 of MOs and ENs), and (5) transfer of patients into palliative care services (58%, 160/274 of MOs and ENs). Interviews underscored the presence of systemic barriers affecting the use of RET molecular tests and selective inhibitors, in addition to suboptimal knowledge and skills necessary to manage the safety and efficacy of targeted therapies. Conclusion This study describes concrete educational needs for providers involved in the care of patients with RET-altered thyroid carcinomas. Findings can be used to inform the design of evidence-based education and performance improvement interventions in the field and support integration into practice of newly approved RET-selective inhibitors." @default.
• W4385791346 created "2023-08-14" @default.
• W4385791346 creator A5004987540 @default.
• W4385791346 creator A5030374801 @default.
• W4385791346 creator A5043675371 @default.
• W4385791346 creator A5049241351 @default.
• W4385791346 creator A5077417152 @default.
• W4385791346 creator A5082092472 @default.
• W4385791346 creator A5088574808 @default.
• W4385791346 creator A5092096127 @default.
• W4385791346 date "2023-08-14" @default.
• W4385791346 modified "2023-10-18" @default.
• W4385791346 title "Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods study" @default.
• W4385791346 cites W1510833811 @default.
• W4385791346 cites W161848051 @default.
• W4385791346 cites W1968517866 @default.
• W4385791346 cites W2007781242 @default.
• W4385791346 cites W2010408856 @default.
• W4385791346 cites W2051782478 @default.
• W4385791346 cites W2054103341 @default.
• W4385791346 cites W2065450371 @default.
• W4385791346 cites W2085001923 @default.
• W4385791346 cites W2085407905 @default.
• W4385791346 cites W2088948434 @default.
• W4385791346 cites W2113559739 @default.
• W4385791346 cites W2116862985 @default.
• W4385791346 cites W2130374691 @default.
• W4385791346 cites W2152129467 @default.
• W4385791346 cites W2166032948 @default.
• W4385791346 cites W2239306219 @default.
• W4385791346 cites W2336519948 @default.
• W4385791346 cites W2343537248 @default.
• W4385791346 cites W2396339611 @default.
• W4385791346 cites W2600348349 @default.
• W4385791346 cites W2604757542 @default.
• W4385791346 cites W2674995983 @default.
• W4385791346 cites W2762027870 @default.
• W4385791346 cites W2768162190 @default.
• W4385791346 cites W2769006626 @default.
• W4385791346 cites W2769536523 @default.
• W4385791346 cites W2770853770 @default.
• W4385791346 cites W2789319038 @default.
• W4385791346 cites W2901292403 @default.
• W4385791346 cites W2921851212 @default.
• W4385791346 cites W2940419730 @default.
• W4385791346 cites W2971355024 @default.
• W4385791346 cites W2991321058 @default.
• W4385791346 cites W3007953816 @default.
• W4385791346 cites W3036917249 @default.
• W4385791346 cites W3039768539 @default.
• W4385791346 cites W3095688018 @default.
• W4385791346 cites W3120168309 @default.
• W4385791346 cites W3124397001 @default.
• W4385791346 cites W3125346997 @default.
• W4385791346 cites W3130567689 @default.
• W4385791346 cites W3132754532 @default.
• W4385791346 cites W3156243085 @default.
• W4385791346 cites W4233302988 @default.
• W4385791346 cites W4252707926 @default.
• W4385791346 doi "https://doi.org/10.1186/s13044-023-00166-4" @default.
• W4385791346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37574538" @default.
• W4385791346 hasPublicationYear "2023" @default.
• W4385791346 type Work @default.
• W4385791346 citedByCount "0" @default.
• W4385791346 crossrefType "journal-article" @default.
• W4385791346 hasAuthorship W4385791346A5004987540 @default.
• W4385791346 hasAuthorship W4385791346A5030374801 @default.
• W4385791346 hasAuthorship W4385791346A5043675371 @default.
• W4385791346 hasAuthorship W4385791346A5049241351 @default.
• W4385791346 hasAuthorship W4385791346A5077417152 @default.
• W4385791346 hasAuthorship W4385791346A5082092472 @default.
• W4385791346 hasAuthorship W4385791346A5088574808 @default.
• W4385791346 hasAuthorship W4385791346A5092096127 @default.
• W4385791346 hasBestOaLocation W43857913461 @default.
• W4385791346 hasConcept C121608353 @default.
• W4385791346 hasConcept C126322002 @default.
• W4385791346 hasConcept C143998085 @default.
• W4385791346 hasConcept C151730666 @default.
• W4385791346 hasConcept C170493617 @default.
• W4385791346 hasConcept C2779343474 @default.
• W4385791346 hasConcept C2779761222 @default.
• W4385791346 hasConcept C2780120053 @default.
• W4385791346 hasConcept C2780333294 @default.
• W4385791346 hasConcept C42362537 @default.
• W4385791346 hasConcept C512399662 @default.
• W4385791346 hasConcept C54355233 @default.
• W4385791346 hasConcept C71924100 @default.
• W4385791346 hasConcept C80227256 @default.
• W4385791346 hasConcept C86803240 @default.
• W4385791346 hasConceptScore W4385791346C121608353 @default.
• W4385791346 hasConceptScore W4385791346C126322002 @default.
• W4385791346 hasConceptScore W4385791346C143998085 @default.
• W4385791346 hasConceptScore W4385791346C151730666 @default.
• W4385791346 hasConceptScore W4385791346C170493617 @default.
• W4385791346 hasConceptScore W4385791346C2779343474 @default.
• W4385791346 hasConceptScore W4385791346C2779761222 @default.
• W4385791346 hasConceptScore W4385791346C2780120053 @default.
• W4385791346 hasConceptScore W4385791346C2780333294 @default.
• W4385791346 hasConceptScore W4385791346C42362537 @default.
• W4385791346 hasConceptScore W4385791346C512399662 @default.

• next